Peru is witnessing a growing need for reliable, high-quality cancer medicines as its healthcare system develops, awareness of cancer increases, and access to modern oncology treatments becomes an increasingly important healthcare priority. However, developing and manufacturing oncology medicines requires specialized facilities, stringent regulatory compliance, and significant investments. These challenges have encouraged Peruvian pharmaceutical companies to